Patents by Inventor Thomas D. Mahon

Thomas D. Mahon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulation and process comprising a solid dispersion of macrolide (tacrolimus)
    Patent number: 8501764
    Abstract: The present invention relates to a pharmaceutical formulation and process for preparing the same comprising an oral dosage formulation, such as a capsule formulation, of a macrolide compound, such as tacrolimus, wherein the capsule formulation contains both a solid dispersion of the macrolide along with a non-dispersed form of the macrolide. The pharmaceutical formulation according to the invention is bioequivalent to the FDA approved product according to a bioavailability study conducted in humans.
    Type: Grant
    Filed: June 13, 2012
    Date of Patent: August 6, 2013
    Assignee: Roxane Laboratories, Inc.
    Inventors: Greg A. Brubaker, Thomas D. Mahon
  • PHARMACEUTICAL FORMULATION AND PROCESS COMPRISING A SOLID DISPERSION OF MACROLIDE (TACROLIMUS)
    Publication number: 20120258143
    Abstract: The present invention relates to a pharmaceutical formulation and process for preparing the same comprising an oral dosage formulation, such as a capsule formulation, of a macrolide compound, such as tacrolimus, wherein the capsule formulation contains both a solid dispersion of the macrolide along with a non-dispersed form of the macrolide. The pharmaceutical formulation according to the invention is bioequivalent to the FDA approved product according to a bioavailability study conducted in humans.
    Type: Application
    Filed: June 13, 2012
    Publication date: October 11, 2012
    Applicant: ROXANE LABORATORIES, INC.
    Inventors: Greg A. Brubaker, Thomas D. Mahon
  • Pharmaceutical formulation and process comprising a solid dispersion of macrolide (tacrolimus)
    Patent number: 8222272
    Abstract: The present invention relates to a pharmaceutical formulation and process for preparing the same comprising an oral dosage formulation, such as a capsule formulation, of a macrolide compound, such as tacrolimus, wherein the capsule formulation contains both a solid dispersion of the macrolide along with a non-dispersed form of the macrolide. The pharmaceutical formulation according to the invention is bioequivalent to the FDA approved product according to a bioavailability study conducted in humans.
    Type: Grant
    Filed: April 11, 2008
    Date of Patent: July 17, 2012
    Assignee: Roxane Laboratories, Inc.
    Inventors: Greg A. Brubaker, Thomas D. Mahon
  • PHARMACEUTICAL FORMULATION AND PROCESS COMPRISING A SOLID DISPERSION OF MACROLIDE (TACROLIMUS)
    Publication number: 20090258895
    Abstract: The present invention relates to a pharmaceutical formulation and process for preparing the same comprising an oral dosage formulation, such as a capsule formulation, of a macrolide compound, such as tacrolimus, wherein the capsule formulation contains both a solid dispersion of the macrolide along with a non-dispersed form of the macrolide. The pharmaceutical formulation according to the invention is bioequivalent to the FDA approved product according to a bioavailability study conducted in humans.
    Type: Application
    Filed: April 11, 2008
    Publication date: October 15, 2009
    Applicant: ROXANE LABORATORIES, INC.
    Inventors: Greg A. BRUBAKER, Thomas D. MAHON